Reduced Burden of Oncologic Therapy in Advanced B-cell Lymphoma (REBOOT ABLY) in Children, Adolescents and Young Adults With CD20+ Mature B-Cell Lymphoma
Phase of Trial: Phase II
Latest Information Update: 18 Mar 2019
At a glance
- Drugs Cytarabine (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Folinic acid; Methotrexate; Prednisone; Rituximab; Vincristine
- Indications Anaplastic large cell lymphoma; B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Acronyms REBOOT; REBOOT ABLY
- 11 Mar 2019 Planned End Date changed from 1 Dec 2019 to 1 Jun 2019.
- 31 Aug 2018 Biomarkers information updated
- 28 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.